SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-096093
Filing Date
2022-08-30
Accepted
2022-08-30 17:00:18
Documents
5
Period of Report
2022-10-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2224754d1_pre14a.htm PRE 14A 306467
2 GRAPHIC tm2224754d1_pre14aimg001.jpg GRAPHIC 18718
3 GRAPHIC tm2224754d1_pre14asp1img001.jpg GRAPHIC 4943
4 GRAPHIC tm2224754d1_pre14asp1img003.jpg GRAPHIC 284371
5 GRAPHIC tm2224754d1_pre14asp1img004.jpg GRAPHIC 269716
  Complete submission text file 0001104659-22-096093.txt   1103830
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38150 | Film No.: 221215249
SIC: 2834 Pharmaceutical Preparations